Cargando…
Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
BACKGROUND: Urinary tract infections (UTI) are often over-diagnosed and over-treated, which can induce and select for resistant pathogens. After observing wide-spread outpatient use of ertapenem, a broad-spectrum antibiotic, a structured antimicrobial stewardship initiative (ASI) to improve appropri...
Autores principales: | Wong, Carrie P., Delate, Thomas, Hudson, Elizabeth, Nguyen, Julia K., Yang, Su-Jau, Abraham, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369658/ https://www.ncbi.nlm.nih.gov/pubmed/34399680 http://dx.doi.org/10.1186/s12879-021-06458-0 |
Ejemplares similares
-
Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing Enterobacteriaceae
por: Ramasubramanian, V., et al.
Publicado: (2018) -
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
por: Mody, Rupal M, et al.
Publicado: (2007) -
Experience with fosfomycin in the treatment of complicated urinary
tract infections caused by extended-spectrum beta-lactamase-producing
Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019) -
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
por: Seo, Yu Bin, et al.
Publicado: (2017) -
Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)